BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 25332241)

  • 21. Antiepileptic Drug-Activated Constitutive Androstane Receptor Inhibits Peroxisome Proliferator-Activated Receptor
    Shizu R; Otsuka Y; Ezaki K; Ishii C; Arakawa S; Amaike Y; Abe T; Hosaka T; Sasaki T; Kanno Y; Miyata M; Yamazoe Y; Yoshinari K
    Mol Pharmacol; 2020 Nov; 98(5):634-647. PubMed ID: 32892155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroxisome proliferator-activated receptor alpha-independent actions of fenofibrate exacerbates left ventricular dilation and fibrosis in chronic pressure overload.
    Duhaney TA; Cui L; Rude MK; Lebrasseur NK; Ngoy S; De Silva DS; Siwik DA; Liao R; Sam F
    Hypertension; 2007 May; 49(5):1084-94. PubMed ID: 17353509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fenofibrate lowers lipid accumulation in myotubes by modulating the PPARα/AMPK/FoxO1/ATGL pathway.
    Chen WL; Chen YL; Chiang YM; Wang SG; Lee HM
    Biochem Pharmacol; 2012 Aug; 84(4):522-31. PubMed ID: 22687626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic alterations in highly tumorigenic glioblastoma cells: preference for hypoxia and high dependency on glycolysis.
    Zhou Y; Zhou Y; Shingu T; Feng L; Chen Z; Ogasawara M; Keating MJ; Kondo S; Huang P
    J Biol Chem; 2011 Sep; 286(37):32843-53. PubMed ID: 21795717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Luteolin induces apoptosis by ROS/ER stress and mitochondrial dysfunction in gliomablastoma.
    Wang Q; Wang H; Jia Y; Pan H; Ding H
    Cancer Chemother Pharmacol; 2017 May; 79(5):1031-1041. PubMed ID: 28393257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lanatoside C sensitizes glioblastoma cells to tumor necrosis factor-related apoptosis-inducing ligand and induces an alternative cell death pathway.
    Badr CE; Wurdinger T; Nilsson J; Niers JM; Whalen M; Degterev A; Tannous BA
    Neuro Oncol; 2011 Nov; 13(11):1213-24. PubMed ID: 21757445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PPARα-ATGL pathway improves muscle mitochondrial metabolism: implication in aging.
    Biswas D; Ghosh M; Kumar S; Chakrabarti P
    FASEB J; 2016 Nov; 30(11):3822-3834. PubMed ID: 27485820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peroxisome proliferator-activated receptor α (PPARα) contributes to control of melanogenesis in B16 F10 melanoma cells.
    Grabacka M; Wieczorek J; Michalczyk-Wetula D; Malinowski M; Wolan N; Wojcik K; Plonka PM
    Arch Dermatol Res; 2017 Apr; 309(3):141-157. PubMed ID: 28084540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fenofibrate A peroxisome proliferator activated receptor-α agonist treatment ameliorates Concanavalin A-induced hepatitis in rats.
    Mohamed DI; Elmelegy AA; El-Aziz LF; Abdel Kawy HS; El-Samad AA; El-Kharashi OA
    Eur J Pharmacol; 2013 Dec; 721(1-3):35-42. PubMed ID: 24140572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delayed treatment with fenofibrate protects against high-fat diet-induced kidney injury in mice: the possible role of AMPK autophagy.
    Sohn M; Kim K; Uddin MJ; Lee G; Hwang I; Kang H; Kim H; Lee JH; Ha H
    Am J Physiol Renal Physiol; 2017 Feb; 312(2):F323-F334. PubMed ID: 27465995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blockage of a miR-21/EGFR regulatory feedback loop augments anti-EGFR therapy in glioblastomas.
    Zhang KL; Han L; Chen LY; Shi ZD; Yang M; Ren Y; Chen LC; Zhang JX; Pu PY; Kang CS
    Cancer Lett; 2014 Jan; 342(1):139-49. PubMed ID: 24012640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-capacity glycolytic and mitochondrial oxidative metabolisms mediate the growth ability of glioblastoma.
    Kim J; Han J; Jang Y; Kim SJ; Lee MJ; Ryu MJ; Kweon GR; Heo JY
    Int J Oncol; 2015 Sep; 47(3):1009-16. PubMed ID: 26202438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of gallic acid on cytotoxicity, Ca(2+) homeostasis and ROS production in DBTRG-05MG human glioblastoma cells and CTX TNA2 rat astrocytes.
    Hsu SS; Chou CT; Liao WC; Shieh P; Kuo DH; Kuo CC; Jan CR; Liang WZ
    Chem Biol Interact; 2016 May; 252():61-73. PubMed ID: 27060209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fenofibrate suppresses growth of the human hepatocellular carcinoma cell via PPARα-independent mechanisms.
    Yamasaki D; Kawabe N; Nakamura H; Tachibana K; Ishimoto K; Tanaka T; Aburatani H; Sakai J; Hamakubo T; Kodama T; Doi T
    Eur J Cell Biol; 2011 Aug; 90(8):657-64. PubMed ID: 21514001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salinomycin induced ROS results in abortive autophagy and leads to regulated necrosis in glioblastoma.
    Xipell E; Gonzalez-Huarriz M; Martinez de Irujo JJ; García-Garzón A; Lang FF; Jiang H; Fueyo J; Gomez-Manzano C; Alonso MM
    Oncotarget; 2016 May; 7(21):30626-41. PubMed ID: 27121320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fenofibrate differentially regulates plasminogen activator inhibitor-1 gene expression via adenosine monophosphate-activated protein kinase-dependent induction of orphan nuclear receptor small heterodimer partner.
    Chanda D; Lee CH; Kim YH; Noh JR; Kim DK; Park JH; Hwang JH; Lee MR; Jeong KH; Lee IK; Kweon GR; Shong M; Oh GT; Chiang JY; Choi HS
    Hepatology; 2009 Sep; 50(3):880-92. PubMed ID: 19593819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fenofibrate simultaneously induces hepatic fatty acid oxidation, synthesis, and elongation in mice.
    Oosterveer MH; Grefhorst A; van Dijk TH; Havinga R; Staels B; Kuipers F; Groen AK; Reijngoud DJ
    J Biol Chem; 2009 Dec; 284(49):34036-44. PubMed ID: 19801551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peroxisome proliferator-activated receptor-alpha gene level differently affects lipid metabolism and inflammation in apolipoprotein E2 knock-in mice.
    Lalloyer F; Wouters K; Baron M; Caron S; Vallez E; Vanhoutte J; Baugé E; Shiri-Sverdlov R; Hofker M; Staels B; Tailleux A
    Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1573-9. PubMed ID: 21474829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of PPARalpha inhibits IGF-I-mediated growth and survival responses in medulloblastoma cell lines.
    Urbanska K; Pannizzo P; Grabacka M; Croul S; Del Valle L; Khalili K; Reiss K
    Int J Cancer; 2008 Sep; 123(5):1015-24. PubMed ID: 18546270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PPARα agonist fenofibrate prevents postoperative cognitive dysfunction by enhancing fatty acid oxidation in mice.
    Liu T; Chen X; Wei Z; Han X; Liu Y; Ma Z; Xia T; Gu X
    Transl Neurosci; 2023 Jan; 14(1):20220317. PubMed ID: 38023298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.